{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:31:52Z","timestamp":1759775512002,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.leukres.2021.106617","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T11:01:04Z","timestamp":1621076464000},"page":"106617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A novel form of anti-angiogenic molecular antibody drug induces apoptosis in myeloma cells after cultivation upon endothelial feeder cells"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6891-0391","authenticated-orcid":false,"given":"Yavar","family":"Yousefi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohreh","family":"Mortezania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3008-114X","authenticated-orcid":false,"given":"Mojdeh","family":"Abolmolouki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1104-4626","authenticated-orcid":false,"given":"Amin","family":"Daemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2021.106617_bib0005","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3389\/fphar.2018.01300","article-title":"Evolution of Cancer Pharmacological treatments at the turn of the third millennium","volume":"9","author":"Falzone","year":"2018","journal-title":"Frontiers in Pharmacol."},{"issue":"1","key":"10.1016\/j.leukres.2021.106617_bib0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40169-017-0175-0","article-title":"Cancer nanomedicine: a review of recent success in drug delivery","volume":"6","author":"Tran","year":"2017","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.leukres.2021.106617_bib0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.leukres.2021.106617_bib0020","article-title":"Chitosan nanoparticles as a drug delivery system","volume":"1","author":"krishna sailaja","year":"2010","journal-title":"RJPBCS"},{"issue":"3","key":"10.1016\/j.leukres.2021.106617_bib0025","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.biomaterials.2006.08.046","article-title":"Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery","volume":"28","author":"Chan","year":"2007","journal-title":"Biomaterials"},{"issue":"1\u20132","key":"10.1016\/j.leukres.2021.106617_bib0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-3659(03)00231-1","article-title":"Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect","volume":"91","author":"Son","year":"2003","journal-title":"J. Controlled Release: Off. J. Controlled Release Soc."},{"issue":"20","key":"10.1016\/j.leukres.2021.106617_bib0035","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1021\/jm800767c","article-title":"Conjugated chitosan as a novel platform for oral delivery of paclitaxel","volume":"51","author":"Lee","year":"2008","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.leukres.2021.106617_bib0040","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jamaoncol.2018.2128","article-title":"Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016","volume":"4","author":"Cowan","year":"2018","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.leukres.2021.106617_bib0045","first-page":"193","article-title":"Innovative agents in multiple myeloma","volume":"5","author":"Faiman","year":"2014","journal-title":"J. Adv. Pract. Oncol."},{"issue":"5","key":"10.1016\/j.leukres.2021.106617_bib0050","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/j.seminoncol.2013.07.002","article-title":"Myeloma: classification and risk assessment","volume":"40","author":"Fonseca","year":"2013","journal-title":"Semin. Oncol."},{"issue":"8","key":"10.1016\/j.leukres.2021.106617_bib0055","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1182\/blood-2003-08-2946","article-title":"Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneity","volume":"103","author":"Asosingh","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2021.106617_bib0060","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.1994.tb08304.x","article-title":"Bone marrow angiogenesis and progression in multiple myeloma","volume":"87","author":"Vacca","year":"1994","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.leukres.2021.106617_bib0065","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2021.106617_bib0070","first-page":"193","article-title":"Innovative agents in multiple myeloma","volume":"5","author":"Faiman","year":"2014","journal-title":"J. Adv. Pract. Oncol."},{"issue":"22","key":"10.1016\/j.leukres.2021.106617_bib0075","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1182\/blood.V114.22.3885.3885","article-title":"The addition of Bevacizumab (B) to Lenalidomide and low dose dexamethasone does not significantly increase response in relapsed or refractory multiple myeloma (NCI#7317)","volume":"114","author":"Callander","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2021.106617_bib0080","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2141.2011.08623.x","article-title":"Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed\/refractory multiple myeloma: a California Cancer consortium trial","volume":"154","author":"Somlo","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.leukres.2021.106617_bib0085","doi-asserted-by":"crossref","DOI":"10.17795\/jjnpp-23082","article-title":"Preparation and in vitro evaluation of chitosan nanoparticles containing diclofenac using the ion-gelation method","volume":"10","author":"Kouchak","year":"2015","journal-title":"Jundishapur J. Nat. Pharm. Prod."},{"issue":"22","key":"10.1016\/j.leukres.2021.106617_bib0090","first-page":"2501","article-title":"Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens","volume":"131","author":"Severson","year":"2018","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"27\u201328","key":"10.1016\/j.leukres.2021.106617_bib0095","first-page":"470","article-title":"The diagnosis and treatment of multiple myeloma","volume":"113","author":"Gerecke","year":"2016","journal-title":"Arztebl. Int."},{"issue":"8","key":"10.1016\/j.leukres.2021.106617_bib0100","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.exphem.2015.04.010","article-title":"Novel therapeutic strategies for multiple myeloma","volume":"43","author":"Mimura","year":"2015","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.leukres.2021.106617_bib0105","doi-asserted-by":"crossref","first-page":"157496","DOI":"10.1155\/2012\/157496","article-title":"Bone marrow microenvironment in multiple myeloma progression","volume":"2012","author":"Manier","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"issue":"31","key":"10.1016\/j.leukres.2021.106617_bib0110","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1038\/sj.onc.1209456","article-title":"Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma","volume":"25","author":"Ribatti","year":"2006","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.leukres.2021.106617_bib0115","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/labinvest.2011.162","article-title":"Bevacizumab attenuates major signaling cascades and eIF4E translation initiation factor in multiple myeloma cells","volume":"92","author":"Attar-Schneider","year":"2012","journal-title":"Lab. Investig."},{"issue":"7","key":"10.1016\/j.leukres.2021.106617_bib0120","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3390\/ijms19072031","article-title":"New insights in anti-angiogenesis in multiple myeloma","volume":"19","author":"Ribatti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.leukres.2021.106617_bib0125","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1080\/21691401.2016.1243545","article-title":"Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation","volume":"45","author":"Pandit","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.leukres.2021.106617_bib0130","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.msec.2019.01.036","article-title":"Chitosan grafted-poly (ethylene glycol) methacrylate nanoparticles as carrier for controlled release of bevacizumab","volume":"98","author":"Savin","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"issue":"1","key":"10.1016\/j.leukres.2021.106617_bib0135","first-page":"1","article-title":"Effect of intravitreal injection of bevacizumab-chitosan nanoparticles on retina of diabetic rats","volume":"7","author":"Lu","year":"2014","journal-title":"Int. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.leukres.2021.106617_bib0140","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood.V93.5.1658","article-title":"Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines","volume":"93","author":"Damiano","year":"1999","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2021.106617_bib0145","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3324\/haematol.2011.047993","article-title":"High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse","volume":"96","author":"Shalapour","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2021.106617_bib0150","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/ijc.26179","article-title":"Inhibition of VEGF induces cellular senescence in colorectal cancer cells","volume":"129","author":"Mohammad","year":"2011","journal-title":"Int. J. Cancer"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621001181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621001181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:01:15Z","timestamp":1758934875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212621001181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":30,"alternative-id":["S0145212621001181"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106617","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel form of anti-angiogenic molecular antibody drug induces apoptosis in myeloma cells after cultivation upon endothelial feeder cells","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106617"}}